Joint/Skin
N-Acetyl D-Glucosamine
Also known as: NAG, N-Acetylglucosamine, GlcNAc
N-Acetyl D-Glucosamine (NAG) is an amino sugar derivative that supports joint cartilage structure and skin barrier function. Evidence for joint health is mixed and moderate, with stronger evidence for gut barrier support.
Primary uses
- Joint health and cartilage support
- Skin barrier function
- Gut barrier integrity
- Inflammatory response modulation
How it works
- Provides substrate for glycosaminoglycan synthesis in cartilage matrix
- Supports mucin production in intestinal lining
- May modulate immune tolerance through dendritic cell signaling
Dosage
- Typical range
- 500-3000 mg daily
- Timing
- Can be taken with or without meals; consistent daily dosing recommended
- With food
- No specific requirement, though may be better tolerated with food
- Duration
- Most studies examining joint benefits used 8-16 week protocols; effects may require consistent use
- Special populations
- Generally safe in pregnancy and lactation; limited pediatric data
Forms
- Powder· 70/100
- Capsule· 70/100
Safety
Common side effects
- Mild gastrointestinal upset
- Nausea
- Heartburn (rare)
Contraindications
- Shellfish allergy (some sources derived from shellfish)
- Severe liver impairment (theoretical concern)
Evidence notes
NAG has shown promise in small studies for joint health, gut barrier support, and inflammatory markers, but larger, well-designed RCTs are limited. Evidence is preliminary and inconsistent, particularly for isolated joint outcomes. Better evidence exists for combinations with glucosamine/chondroitin than NAG alone.
Grade C: Mostly observational or small trials; mechanism is plausible but unproven at scale.
Related in Joint/Skin
Check a full stack
Formulate's free interaction checker lets you paste in any combination of supplements and medications at once — every pairing flags severity, timing, and cited evidence.
Open the checkerMedical disclaimer. This page is educational and does not replace advice from a qualified healthcare provider.